Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...
Palm Beach, FL – March 10, 2025 – A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 billion in 2024 to ...
Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.
Aclarion, Inc. (NASDAQ:ACON) experienced a dramatic decrease of 74.13% in its stock price. Elevai Labs, Inc. (ELAB) saw a substantial price drop of 42.63%. Sleep Number Corporation (SNBR) reported a ...
Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...
The additional sites RadNet is onboarding will help us enable more convenient access to grow scan volume in response to physician demand. It also underscores our strong relationship with this ...
Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ('Conduit Pharmaceuticals' or 'Conduit' or the 'Company”) announces that, on February 11, 2025, the Company presented its plan of compliance to The Nasdaq ...
Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 1% on Thursday. Following the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback